Nguyen HM - Search Results

1

A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening.

Beshiri ML, Tice CM, Tran C, Nguyen HM, Sowalsky AG, Agarwal S, Jansson KH, Yang Q, McGowen KM, Yin J, Alilin AN, Karzai FH, Dahut WL, Corey E, Kelly K. Beshiri ML, et al. Among authors: nguyen hm. Clin Cancer Res. 2018 Sep 1;24(17):4332-4345. doi: 10.1158/1078-0432.CCR-18-0409. Epub 2018 May 10. Clin Cancer Res. 2018. PMID: 29748182 Free PMC article.

2

Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis.

Koreckij T, Nguyen H, Brown LG, Yu EY, Vessella RL, Corey E. Koreckij T, et al. Br J Cancer. 2009 Jul 21;101(2):263-8. doi: 10.1038/sj.bjc.6605178. Br J Cancer. 2009. PMID: 19603032 Free PMC article.

3

HE3235 inhibits growth of castration-resistant prostate cancer.

Koreckij TD, Trauger RJ, Montgomery RB, Pitts TE, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E. Koreckij TD, et al. Neoplasia. 2009 Nov;11(11):1216-25. doi: 10.1593/neo.09960. Neoplasia. 2009. PMID: 19881957 Free PMC article.

4

Low dose, alternating electric current inhibits growth of prostate cancer.

Koreckij TD, Hill C, Azure L, Nguyen H, Kunz LL, Azure A, Corey E, Lange P, Vessella RL. Koreckij TD, et al. Prostate. 2010 Apr 1;70(5):529-39. doi: 10.1002/pros.21087. Prostate. 2010. PMID: 19938042

5

Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability.

Morrissey C, Dowell A, Koreckij TD, Nguyen H, Lakely B, Fanslow WC, True LD, Corey E, Vessella RL. Morrissey C, et al. Prostate. 2010 Dec 1;70(16):1799-808. doi: 10.1002/pros.21216. Prostate. 2010. PMID: 20583134 Free PMC article.

6

Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.

Putzke AP, Ventura AP, Bailey AM, Akture C, Opoku-Ansah J, Celiktaş M, Hwang MS, Darling DS, Coleman IM, Nelson PS, Nguyen HM, Corey E, Tewari M, Morrissey C, Vessella RL, Knudsen BS. Putzke AP, et al. Among authors: nguyen hm. Am J Pathol. 2011 Jul;179(1):400-10. doi: 10.1016/j.ajpath.2011.03.028. Epub 2011 May 4. Am J Pathol. 2011. PMID: 21703419 Free PMC article.

7

Methodology to investigate androgen-sensitive and castration-resistant human prostate cancer xenografts in preclinical setting.

Nguyen HM, Corey E. Nguyen HM, et al. Methods Mol Biol. 2011;776:295-312. doi: 10.1007/978-1-61779-243-4_17. Methods Mol Biol. 2011. PMID: 21796533

8

Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bone.

Kirk PS, Koreckij T, Nguyen HM, Brown LG, Snyder LA, Vessella RL, Corey E. Kirk PS, et al. Among authors: nguyen hm. Int J Mol Sci. 2013 May 21;14(5):10483-96. doi: 10.3390/ijms140510483. Int J Mol Sci. 2013. PMID: 23698775 Free PMC article.

9

Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling.

Nguyen HM, Ruppender N, Zhang X, Brown LG, Gross TS, Morrissey C, Gulati R, Vessella RL, Schimmoller F, Aftab DT, Corey E. Nguyen HM, et al. PLoS One. 2013 Oct 25;8(10):e78881. doi: 10.1371/journal.pone.0078881. eCollection 2013. PLoS One. 2013. PMID: 24205338 Free PMC article.

10

Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts.

DiPippo VA, Olson WC, Nguyen HM, Brown LG, Vessella RL, Corey E. DiPippo VA, et al. Among authors: nguyen hm. Prostate. 2015 Feb 15;75(3):303-13. doi: 10.1002/pros.22916. Epub 2014 Oct 18. Prostate. 2015. PMID: 25327986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

521 results

Search Page

Filters